Mahickra Chem.

When is the next results date for Mahickra Chem.?

No Upcoming Board Meetings

Has Mahickra Chem. declared dividend?

Mahickra Chemicals Ltd has declared a 2% dividend, amounting to ₹0.2 per share, with an ex-date of March 18, 2025. The company has shown strong total returns across various periods, including a 70.68% total return over the last 5 years.

Mahickra Chemicals Ltd has declared a 2% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 2%<BR>- Amount per share: 0.2<BR>- Ex-date: 18 Mar 25<BR><BR>Dividend Yield: 0.16%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, Mahickra Chemicals Ltd experienced a price return of 12.44%, a dividend return of 0.19%, resulting in a total return of 12.63%.<BR><BR>Over the past year, the company achieved a price return of 9.91%, a dividend return of 0.18%, leading to a total return of 10.09%.<BR><BR>In the 2-year period, the price return was 43.36%, with a dividend return of 0.62%, culminating in a total return of 43.98%.<BR><BR>For the 3-year period, the company reported a price return of 54.53%, a dividend return of 1.58%, which resulted in a total return of 56.11%.<BR><BR>In the last 4 years, Mahickra Chemicals Ltd had a price return of 35.71%, with a dividend return of 1.93%, bringing the total return to 37.64%.<BR><BR>Over the 5-year period, the price return was 68.04%, alongside a dividend return of 2.64%, resulting in a total return of 70.68%.<BR><BR>Overall, Mahickra Chemicals Ltd has declared a modest dividend while demonstrating strong total returns across various periods, indicating a positive performance trend for investors.

What is the technical trend for Mahickra Chem.?

As of June 3, 2025, Mahickra Chem's trend is mildly bullish, supported by a bullish weekly MACD and Bollinger Bands, despite mixed signals from the KST, Dow Theory, RSI, and OBV.

As of 3 June 2025, the technical trend for Mahickra Chem has changed from bullish to mildly bullish. The weekly MACD remains bullish, supported by bullish signals from the Bollinger Bands and daily moving averages. However, the KST shows a mildly bearish stance on the monthly timeframe, and the Dow Theory indicates a bearish trend on the weekly chart. The RSI shows no signal on both weekly and monthly timeframes, and the OBV is mildly bearish on the weekly. Overall, the current stance is mildly bullish, driven primarily by the weekly MACD and Bollinger Bands, despite some mixed signals from other indicators.

Who are the peers of the Mahickra Chem.?

Mahickra Chem.'s peers include Indian Emuls, Jocil, Vital Chemtech, and others, with varying management risks and growth rates. Mahickra Chem. has a 1-year return of 23.91%, outperforming Indian Emuls but underperforming Jocil.

Peers: The peers of Mahickra Chem. are Indian Emuls, Jocil, Vital Chemtech, Indian Phosphate, Paragon Fine, Par Drugs & Che., Unilex Colour &C, Ushanti Colour, Vadivarhe Speci.<BR><BR>Quality Snapshot: Excellent management risk is observed at Indian Emuls, while Good management risk is found at Indian Phosphate and Paragon Fine, and Average management risk is present at Jocil, Vital Chemtech, Par Drugs & Che., and Mahickra Chem. Below Average management risk is noted at Unilex Colour &C, Ushanti Colour, Vadivarhe Speci., and Sanginita Chemi. Growth is Excellent at Indian Emuls, while Average growth is seen at Mahickra Chem., and Below Average growth is noted at Jocil, Vital Chemtech, Indian Phosphate, Paragon Fine, Par Drugs & Che., Unilex Colour &C, Ushanti Colour, Vadivarhe Speci., and Sanginita Chemi. Capital Structure is Excellent at Jocil and Par Drugs & Che., Good at Indian Phosphate and Paragon Fine, Average at Indian Emuls, Vital Chemtech, and Mahickra Chem., and Below Average at Unilex Colour &C, Ushanti Colour, Vadivarhe Speci., and Sanginita Chemi.<BR><BR>Return Snapshot: Mahickra Chem. has a 1-year return of 23.91%, which is higher than the lowest peer, Indian Emuls, at -63.70%, and lower than the highest peer, Jocil, at -13.96%. Additionally, several peers, including Indian Emuls, Vital Chemtech, Paragon Fine, Par Drugs & Che., Ushanti Colour, Vadivarhe Speci., and Sanginita Chemi., have negative six-month returns.

Who are in the management team of Mahickra Chem.?

As of March 2023, the management team of Mahickra Chem includes Miteshkumar Champaklal Gandhi (Chairman & Managing Director), Ashishkumar Champaklal Gandhi and Komal Mitesh Gandhi (Whole-time Directors), Amisha Fenil Shah, Niren Atinbhai Desai, and Basari Mehta (Independent Directors), and Sona Bachani (Company Secretary & Compliance Officer).

As of March 2023, the management team of Mahickra Chem includes the following individuals:<BR><BR>1. Miteshkumar Champaklal Gandhi - Chairman & Managing Director<BR>2. Ashishkumar Champaklal Gandhi - Whole-time Director<BR>3. Komal Mitesh Gandhi - Whole-time Director<BR>4. Amisha Fenil Shah - Independent Director<BR>5. Sona Bachani - Company Secretary & Compliance Officer<BR>6. Niren Atinbhai Desai - Independent Director<BR>7. Basari Mehta - Independent Director<BR><BR>These members play various roles within the company, contributing to its governance and operational management.

What does Mahickra Chem. do?

Mahickra Chemicals Ltd manufactures and trades Reactive Dyes in the Chemicals & Petrochemicals industry. Established in 1994 and rebranded in 2017, it operates as a Micro Cap company with a market cap of INR 112 Cr.

Overview:<BR>Mahickra Chemicals Ltd is engaged in the manufacturing and trading of Reactive Dyes within the Chemicals & Petrochemicals industry, categorized as a Micro Cap company.<BR><BR>History:<BR>Mahickra Chemicals Ltd was originally established as a Partnership Firm named 'Mahak Dye Chem Industries' in 1994. It transitioned to a Public Limited Company and rebranded to "Mahickra Chemicals Limited" on November 13, 2017. The company has been manufacturing Reactive Dyes since 1998, while trading in Reactive Dyes commenced in 1994. Revenue and profit data for the latest quarter are not available.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 112 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 43.00<BR>Industry P/E: 47<BR>Dividend Yield: 0.15%<BR>Debt-Equity: 0.40<BR>Return on Equity: 7.59%<BR>Price-to-Book: 3.30<BR><BR>Contact Details:<BR>Address: Plot No 1209 Phase-3, GIDC Vatva Ahmedabad Gujarat : 382445<BR>Tel: 91-079-25890811/25832692<BR>Email: info@mahickra.com<BR>Website: http://www.mahickra.com

Who are the top shareholders of the Mahickra Chem.?

The top shareholders of Mahickra Chem include Ashishkumar Champaklal Gandhi with 16.23%, individual investors with 41.69%, and the National Stock Exchange Of India Limited Account Karvy Stock Broking Limited at 2.22%. There are no pledged promoter holdings or mutual funds involved.

The top shareholders of Mahickra Chem include Ashishkumar Champaklal Gandhi, who holds the largest stake at 16.23%. Additionally, individual investors collectively own 41.69% of the shares. The highest public shareholder is the National Stock Exchange Of India Limited Account Karvy Stock Broking Limited, with a holding of 2.22%. There is also one Foreign Institutional Investor (FII) that holds 0.59% of the shares. Notably, there are no pledged promoter holdings and no mutual funds involved.

How big is Mahickra Chem.?

As of 23rd July, Mahickra Chemicals Ltd has a market capitalization of 111.00 Cr, classifying it as a Micro Cap company. Recent quarterly performance data, including Net Sales and Net Profit, is unavailable, while shareholder's funds are valued at 33.33 Cr and total assets at 60.78 Cr as of March 2024.

As of 23rd July, Mahickra Chemicals Ltd has a market capitalization of 111.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent quarterly performance data is not available, so there are no figures for Net Sales or Net Profit for the latest four quarters.<BR><BR>The reporting period for the balance sheet is March 2024. Shareholder's Funds are valued at 33.33 Cr, and Total Assets amount to 60.78 Cr.

Is Mahickra Chem. overvalued or undervalued?

As of August 28, 2025, Mahickra Chem. is considered very expensive with a PE ratio of 48.12 and other high valuation metrics, indicating overvaluation compared to peers and raising concerns about its growth prospects despite a strong recent performance.

As of 28 August 2025, Mahickra Chem. has moved from a fair valuation to very expensive, indicating a significant shift in its perceived market value. The company is currently overvalued, with a PE ratio of 48.12, an EV to EBITDA of 54.07, and a Price to Book Value of 3.65. These ratios suggest that the stock is trading at a premium compared to its earnings and book value, which raises concerns about sustainability.<BR><BR>In comparison to its peers, Mahickra Chem.'s valuation stands out as particularly high; for instance, Godrej Industries, which is rated attractive, has a PE ratio of 41.86, while Solar Industries, also very expensive, trades at a PE of 99.06. The disparity in these valuations highlights that Mahickra Chem. is not only overvalued relative to its immediate competitors but also raises questions about its growth prospects given its low ROCE of 4.71% and ROE of 7.59%. Notably, Mahickra Chem. has outperformed the Sensex in various time frames, including a 39.05% return over the past year, which may contribute to the inflated valuation despite the underlying financial metrics suggesting caution.

How has been the historical performance of Mahickra Chem.?

Mahickra Chem. has shown mixed historical performance, with net sales increasing to 88.16 Cr in March 2025 but declining from previous years, while profit metrics improved. However, the company faces challenges in revenue stability and cash flow management.

Answer:<BR>The historical performance of Mahickra Chem. shows fluctuations in key financial metrics over the past four years.<BR><BR>Breakdown:<BR>Mahickra Chem. reported net sales of 88.16 Cr in March 2025, an increase from 71.92 Cr in March 2024, but a decline from 103.03 Cr in March 2023 and 102.30 Cr in March 2022. Total operating income mirrored this trend, reaching 88.16 Cr in March 2025. The raw material cost rose significantly to 80.93 Cr in March 2025 from 62.06 Cr in March 2024, while total expenditure also increased to 85.66 Cr in March 2025. Operating profit (PBDIT) improved to 5.12 Cr in March 2025, up from 2.95 Cr in March 2024, but down from 6.05 Cr in March 2023. Profit before tax was 3.53 Cr in March 2025, compared to 1.50 Cr in March 2024, while profit after tax increased to 2.53 Cr from 1.07 Cr. The earnings per share (EPS) rose to 3.12 in March 2025 from 1.32 in March 2024. On the balance sheet, total assets increased to 68.28 Cr in March 2025, up from 60.78 Cr in March 2024, with total liabilities also rising to 68.28 Cr. Cash flow from operating activities showed no inflow in March 2025, reflecting a challenging cash position. Overall, Mahickra Chem. has experienced a mixed performance with improvements in profit metrics but challenges in revenue stability and cash flow management.

Why is Mahickra Chemicals Ltd falling/rising?

As of 01-Apr, Mahickra Chemicals Ltd's stock price is rising to 215.00, reflecting a 1.42% increase. This upward trend is supported by strong performance compared to the Sensex, with significant gains over various time frames, despite a decline in investor participation.

As of 01-Apr, Mahickra Chemicals Ltd's stock price is rising, currently at 215.00, reflecting a change of 3.0 (1.42%) upward. This increase can be attributed to the stock's strong performance relative to the benchmark Sensex, with Mahickra Chemicals showing a 1-week return of +4.37% compared to the Sensex's -2.69%. Over the past month, the stock has gained +16.22%, while the Sensex has declined by -9.93%. Year-to-date, Mahickra Chemicals has risen by +44.73%, significantly outperforming the Sensex, which is down -13.20%.<BR><BR>Additionally, the stock is trading above its moving averages across various time frames, indicating a positive trend. However, it is important to note that there has been a decline in investor participation, with delivery volume dropping by -65.52% against the 5-day average. Despite this decrease in participation, the overall upward movement in price and strong historical performance suggest that the stock is currently on an upward trajectory.

Which are the latest news on Mahickra Chem.?